房颤的筛查和社区管理的研究进展
Research Progress of Screening and Community Management of Atrial Fibrillation
DOI: 10.12677/acm.2025.1572162, PDF,    科研立项经费支持
作者: 吴 航, 弥夏夏, 张 斌, 杨文博, 梁泽润, 陈雨欣:西安医学院第一附属医院全科医学科,陕西 西安;西安医学院研究生工作部,陕西 西安;于照祥, 崔 洁*:西安医学院第一附属医院全科医学科,陕西 西安
关键词: 心房颤动筛查社区管理抗凝可穿戴设备综述Atrial Fibrillation Screening Community Management Anticoagulation Wearable Devices Review
摘要: 随着人口老龄化和生活方式改变,心房颤动(房颤)发病率显著上升,已成为全球重大公共卫生问题。房颤不仅降低患者生活质量,还显著增加卒中、心力衰竭及认知功能障碍等风险。全科医生在房颤社区管理中发挥关键作用,通过早期筛查、健康教育、风险评估、持续监测及综合干预,可提高房颤识别率并优化治疗依从性。当前,房颤筛查手段趋于多样化,社区管理强调多学科协作与个体化诊疗,结合信息化工具构建动态管理系统。然而,我国社区房颤管理仍面临知晓率低、抗凝治疗率不足等问题。本文系统综述国内外房颤筛查技术及社区管理模式的研究进展,分析现存问题并提出改进方向,以期为优化房颤防控策略提供参考。
Abstract: With the aging population and lifestyle changes, the incidence of atrial fibrillation (AF) has risen significantly, emerging as a critical global public health issue. AF not only diminishes patients’ quality of life but also substantially elevates the risks of stroke, heart failure, and cognitive impairment. General practitioners play a pivotal role in community-based AF management by implementing early screening, health education, risk assessment, continuous monitoring, and comprehensive interventions, which can enhance AF detection rates and optimize treatment adherence. Current AF screening approaches are increasingly diversified, while community management emphasizes multidisciplinary collaboration and personalized treatment approaches, supported by dynamic systems integrating digital health tools. However, challenges persist in China, including low public awareness and inadequate anticoagulation rates. This review systematically examines advancements in AF screening technologies and community management models worldwide, analyzes existing limitations, and proposes strategies for improvement, aiming to provide insights for optimizing AF prevention and control strategies.
文章引用:吴航, 弥夏夏, 于照祥, 张斌, 杨文博, 梁泽润, 陈雨欣, 崔洁. 房颤的筛查和社区管理的研究进展[J]. 临床医学进展, 2025, 15(7): 1592-1604. https://doi.org/10.12677/acm.2025.1572162

参考文献

[1] Elliott, A.D., Middeldorp, M.E., Van Gelder, I.C., Albert, C.M. and Sanders, P. (2023) Epidemiology and Modifiable Risk Factors for Atrial Fibrillation. Nature Reviews Cardiology, 20, 404-417. [Google Scholar] [CrossRef] [PubMed]
[2] Davidson, K.W., Barry, M.J., Mangione, C.M., Cabana, M., Caughey, A.B., Davis, E.M., et al. (2022) Screening for Atrial Fibrillation: Us Preventive Services Task Force Recommendation Statement. JAMA, 327, 360-367. [Google Scholar] [CrossRef] [PubMed]
[3] Kahwati, L.C., Asher, G.N., Kadro, Z.O., Keen, S., Ali, R., Coker-Schwimmer, E., et al. (2022) Screening for Atrial Fibrillation: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA, 327, 368-383. [Google Scholar] [CrossRef] [PubMed]
[4] Andersen, J.H., Andreasen, L. and Olesen, M.S. (2020) Atrial Fibrillation—A Complex Polygenetic Disease. European Journal of Human Genetics, 29, 1051-1060. [Google Scholar] [CrossRef] [PubMed]
[5] Chung, M.K., Refaat, M., Shen, W., Kutyifa, V., Cha, Y., Di Biase, L., et al. (2020) Atrial Fibrillation. Journal of the American College of Cardiology, 75, 1689-1713. [Google Scholar] [CrossRef] [PubMed]
[6] Du, X., Guo, L., Xia, S., Du, J., Anderson, C., Arima, H., et al. (2021) Atrial Fibrillation Prevalence, Awareness and Management in a Nationwide Survey of Adults in China. Heart, 107, 535-541. [Google Scholar] [CrossRef] [PubMed]
[7] Pokorney, S.D., Piccini, J.P., Stevens, S.R., et al. (2016) Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients with Nonvalvular Atrial Fibrillation: Data from ROCKET AF. Journal of the American Heart As-sociation, 5, e002197.
[8] Wang, Z., Chen, Z., Wang, X., Zhang, L., Li, S., Tian, Y., et al. (2018) The Disease Burden of Atrial Fibrillation in China from a National Cross-Sectional Survey. The American Journal of Cardiology, 122, 793-798. [Google Scholar] [CrossRef] [PubMed]
[9] Joseph, P.G., Healey, J.S., Raina, P., Connolly, S.J., Ibrahim, Q., Gupta, R., et al. (2020) Global Variations in the Prevalence, Treatment, and Impact of Atrial Fibrillation in a Multi-National Cohort of 153 152 Middle-Aged Individuals. Cardiovascular Research, 117, 1523-1531. [Google Scholar] [CrossRef] [PubMed]
[10] Wang, X., Fu, Q., Song, F., Li, W., Yin, X., Yue, W., et al. (2018) Prevalence of Atrial Fibrillation in Different Socioeconomic Regions of China and Its Association with Stroke: Results from a National Stroke Screening Survey. International Journal of Cardiology, 271, 92-97. [Google Scholar] [CrossRef] [PubMed]
[11] Li, Y. and Lip, G.Y.H. (2019) Stroke Prevention in Atrial Fibrillation: State of the Art. International Journal of Cardiology, 287, 201-209. [Google Scholar] [CrossRef] [PubMed]
[12] Ruddox, V., Sandven, I., Munkhaugen, J., Skattebu, J., Edvardsen, T. and Otterstad, J.E. (2017) Atrial Fibrillation and the Risk for Myocardial Infarction, All-Cause Mortality and Heart Failure: A Systematic Review and Meta-Analysis. European Journal of Preventive Cardiology, 24, 1555-1566. [Google Scholar] [CrossRef] [PubMed]
[13] Curry, S.J., Krist, A.H., Owens, D.K., Barry, M.J., Caughey, A.B., Davidson, K.W., et al. (2018) Screening for Atrial Fibrillation with Electrocardiography. JAMA, 320, 478-484. [Google Scholar] [CrossRef] [PubMed]
[14] Lip, G.Y.H., Fauchier, L., Freedman, S.B., Van Gelder, I., Natale, A., Gianni, C., et al. (2016) Atrial Fibrillation. Nature Reviews Disease Primers, 2, Article No. 16016. [Google Scholar] [CrossRef] [PubMed]
[15] Chugh, S.S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E.J., et al. (2014) Worldwide Epidemiology of Atrial Fibrillation. Circulation, 129, 837-847. [Google Scholar] [CrossRef] [PubMed]
[16] Dilaveris, P.E. and Kennedy, H.L. (2017) Silent Atrial Fibrillation: Epidemiology, Diagnosis, and Clinical Impact. Clinical Cardiology, 40, 413-418. [Google Scholar] [CrossRef] [PubMed]
[17] Freedman, B., Camm, J., Calkins, H., Healey, J.S., Rosenqvist, M., Wang, J., et al. (2017) Screening for Atrial Fibrillation. Circulation, 135, 1851-1867. [Google Scholar] [CrossRef] [PubMed]
[18] Li, L., Sheng, C., Hu, B., Huang, Q., Zeng, W., Li, G., et al. (2015) The Prevalence, Incidence, Management and Risks of Atrial Fibrillation in an Elderly Chinese Population: A Prospective Study. BMC Cardiovascular Disorders, 15, Article No. 31. [Google Scholar] [CrossRef] [PubMed]
[19] Steinhubl, S.R., Waalen, J., Edwards, A.M., Ariniello, L.M., Mehta, R.R., Ebner, G.S., et al. (2018) Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation. JAMA, 320, 146-155. [Google Scholar] [CrossRef] [PubMed]
[20] Svennberg, E., Friberg, L., Frykman, V., Al-Khalili, F., Engdahl, J. and Rosenqvist, M. (2021) Clinical Outcomes in Systematic Screening for Atrial Fibrillation (STROKESTOP): A Multicentre, Parallel Group, Unmasked, Randomised Controlled Trial. The Lancet, 398, 1498-1506. [Google Scholar] [CrossRef] [PubMed]
[21] Svennberg, E. and Engdahl, J. (2017) Screening for Atrial Fibrillation in 13 122 Hong Kong Citizens with Smartphone Electro-Cardiogram. Heart, 103, 6-7.
[22] Ramkumar, S., Nerlekar, N., D’Souza, D., Pol, D.J., Kalman, J.M. and Marwick, T.H. (2018) Atrial Fibrillation Detection Using Single Lead Portable Electrocardiographic Monitoring: A Systematic Review and Meta-Analysis. BMJ Open, 8, e024178. [Google Scholar] [CrossRef] [PubMed]
[23] Lowres, N., Olivier, J., Chao, T., Chen, S., Chen, Y., Diederichsen, A., et al. (2019) Estimated Stroke Risk, Yield, and Number Needed to Screen for Atrial Fibrillation Detected through Single Time Screening: A Multicountry Patient-Level Meta-Analysis of 141,220 Screened Individuals. PLOS Medicine, 16, e1002903. [Google Scholar] [CrossRef] [PubMed]
[24] Siontis, K.C., Gersh, B.J., Killian, J.M., Noseworthy, P.A., McCabe, P., Weston, S.A., et al. (2016) Typical, Atypical, and Asymptomatic Presentations of New-Onset Atrial Fibrillation in the Community: Characteristics and Prognostic Implications. Heart Rhythm, 13, 1418-1424. [Google Scholar] [CrossRef] [PubMed]
[25] Fay, M.R., Fitzmaurice, D.A. and Freedman, B. (2017) Screening of Older Patients for Atrial Fibrillation in General Practice: Current Evidence and Its Implications for Future Practice. European Journal of General Practice, 23, 246-253. [Google Scholar] [CrossRef] [PubMed]
[26] Brieger, D., Amerena, J., Attia, J., Bajorek, B., Chan, K.H., Connell, C., et al. (2018) National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018. Heart, Lung and Circulation, 27, 1209-1266. [Google Scholar] [CrossRef] [PubMed]
[27] Hart, R.G., Pearce, L.A. and Aguilar, M.I. (2007) Meta-Analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation. Annals of Internal Medicine, 146, 857-867. [Google Scholar] [CrossRef] [PubMed]
[28] Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., et al. (2016) 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with EACTs. European Heart Journal, 37, 2893-2962. [Google Scholar] [CrossRef] [PubMed]
[29] Joglar, J.A., Chung, M.K., Armbruster, A.L., Benjamin, E.J., Chyou, J.Y., Cronin, E.M., et al. (2024) 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 149, e167. [Google Scholar] [CrossRef] [PubMed]
[30] Mendonça, S.C., Edwards, D.A., Lund, J., Saunders, C.L. and Mant, J. (2023) Progression of Stroke Risk in Patients Aged < 65 Years Diagnosed with Atrial Fibrillation: A Cohort Study in General Practice. British Journal of General Practice, 73, e825-e831. [Google Scholar] [CrossRef] [PubMed]
[31] McKenzie, K., Lowres, N., Orchard, J., Hespe, C., Freedman, B. and Giskes, K. (2022) Staff Acceptability and Patient Usability of a Self-Screening Kiosk for Atrial Fibrillation in General Practice Waiting Rooms. Cardiovascular Digital Health Journal, 3, 212-219. [Google Scholar] [CrossRef] [PubMed]
[32] Lyth, J., Svennberg, E., Bernfort, L., Aronsson, M., Frykman, V., Al-Khalili, F., et al. (2022) Cost-Effectiveness of Population Screening for Atrial Fibrillation: The STROKESTOP Study. European Heart Journal, 44, 196-204. [Google Scholar] [CrossRef] [PubMed]
[33] Oguz, M., Lanitis, T., Li, X., Wygant, G., Singer, D.E., Friend, K., et al. (2019) Cost-Effectiveness of Extended and One-Time Screening versus No Screening for Non-Valvular Atrial Fibrillation in the USA. Applied Health Economics and Health Policy, 18, 533-545. [Google Scholar] [CrossRef] [PubMed]
[34] Chen, W., Khurshid, S., Singer, D.E., Atlas, S.J., Ashburner, J.M., Ellinor, P.T., et al. (2022) Cost-Effectiveness of Screening for Atrial Fibrillation Using Wearable Devices. JAMA Health Forum, 3, e222419. [Google Scholar] [CrossRef] [PubMed]
[35] Orchard, J.F.S., Lowres, N., Peiris, D. and Neubeck, L. (2014) iPhone ECG Screening by Practice Nurses and Receptionists for Atrial Fibrillation in General Practice: The GP-SEARCH Qualitative Pilot Study. Australian Family Physician, 43, 315-319.
[36] Lau, J.K., Lowres, N., Neubeck, L., Brieger, D.B., Sy, R.W., Galloway, C.D., et al. (2013) iPhone ECG Application for Community Screening to Detect Silent Atrial Fibrillation: A Novel Technology to Prevent Stroke. International Journal of Cardiology, 165, 193-194. [Google Scholar] [CrossRef] [PubMed]
[37] Orchard, J., Lowres, N., Freedman, S.B., Ladak, L., Lee, W., Zwar, N., et al. (2016) Screening for Atrial Fibrillation during Influenza Vaccinations by Primary Care Nurses Using a Smartphone Electrocardiograph (IECG): A Feasibility Study. European Journal of Preventive Cardiology, 23, 13-20. [Google Scholar] [CrossRef] [PubMed]
[38] Hindricks, G., Potpara, T., Dagres, N., et al. (2021) 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 42, 373-498.
[39] Orchard, J., Neubeck, L., Freedman, B., Li, J., Webster, R., Zwar, N., et al. (2019) eHealth Tools to Provide Structured Assistance for Atrial Fibrillation Screening, Management, and Guideline‐Recommended Therapy in Metropolitan General Practice: The AF‐SMART Study. Journal of the American Heart Association, 8, e010959. [Google Scholar] [CrossRef] [PubMed]
[40] 姚易, 廖晓阳, 李志超. 计算机辅助诊断模型助力基层医疗机构诊断阵发性心房颤动[J]. 中国全科医学, 2021, 24(2): 143-147.
[41] Peiris, D., Usherwood, T., Panaretto, K., Harris, M., Hunt, J., Patel, B., et al. (2012) The Treatment of Cardiovascular Risk in Primary Care Using Electronic Decision Support (TORPEDO) Study: Intervention Development and Protocol for a Cluster Randomised, Controlled Trial of an Electronic Decision Support and Quality Improvement Intervention in Australian Primary Healthcare. BMJ Open, 2, e002177. [Google Scholar] [CrossRef] [PubMed]
[42] Orchard, J., Li, J., Gallagher, R., Freedman, B., Lowres, N. and Neubeck, L. (2019) Uptake of a Primary Care Atrial Fibrillation Screening Program (AF-SMART): A Realist Evaluation of Implementation in Metropolitan and Rural General Practice. BMC Family Practice, 20, Article No. 170. [Google Scholar] [CrossRef] [PubMed]
[43] Orchard, J., Li, J., Freedman, B., Webster, R., Salkeld, G., Hespe, C., et al. (2020) Atrial Fibrillation Screen, Management, and Guideline‐Recommended Therapy in the Rural Primary Care Setting: A Cross‐Sectional Study and Cost‐Effectiveness Analysis of eHealth Tools to Support All Stages of Screening. Journal of the American Heart Association, 9, e017080. [Google Scholar] [CrossRef] [PubMed]
[44] Giskes, K., Lowres, N., Orchard, J., Li, J., McKenzie, K., Hespe, C.M., et al. (2022) Increasing Screening for Atrial Fibrillation in General Practice: The Atrial Fibrillation Self‐Screening, Management and guideline‐recommended Therapy (AF Self‐Smart) Study. Medical Journal of Australia, 218, 27-32. [Google Scholar] [CrossRef] [PubMed]
[45] Park, S., Gopalsamy, C., Rajamanickam, R., et al. (1999) The Wearable Motherboard: A Flexible Information Infrastructure or Sensate Liner for Medical Applications. Studies in Health Technology and Informatics, 62, 252-258.
[46] Steinhubl, S.R., Mehta, R.R., Ebner, G.S., Ballesteros, M.M., Waalen, J., Steinberg, G., et al. (2016) Rationale and Design of a Home-Based Trial Using Wearable Sensors to Detect Asymptomatic Atrial Fibrillation in a Targeted Population: The mHealth Screening to Prevent Strokes (mSToPS) Trial. American Heart Journal, 175, 77-85. [Google Scholar] [CrossRef] [PubMed]
[47] Pepplinkhuizen, S., Hoeksema, W.F., van der Stuijt, W., van Steijn, N.J., Winter, M.M., Wilde, A.A.M., et al. (2022) Accuracy and Clinical Relevance of the Single-Lead Apple Watch Electrocardiogram to Identify Atrial Fibrillation. Cardiovascular Digital Health Journal, 3, S17-S22. [Google Scholar] [CrossRef] [PubMed]
[48] Khurshid, S., Chen, W., Singer, D.E., Atlas, S.J., Ashburner, J.M., Choi, J.G., et al. (2021) Comparative Clinical Effectiveness of Population‐Based Atrial Fibrillation Screening Using Contemporary Modalities: A Decision‐Analytic Model. Journal of the American Heart Association, 10, e020330. [Google Scholar] [CrossRef] [PubMed]
[49] Poh, M., Battisti, A.J., Cheng, L., Lin, J., Patwardhan, A., Venkataraman, G.S., et al. (2023) Validation of a Deep Learning Algorithm for Continuous, Real‐Time Detection of Atrial Fibrillation Using a Wrist‐Worn Device in an Ambulatory Environment. Journal of the American Heart Association, 12, e030543. [Google Scholar] [CrossRef] [PubMed]
[50] Verbrugge, F.H., Proesmans, T., Vijgen, J., Mullens, W., Rivero-Ayerza, M., Van Herendael, H., et al. (2019) Atrial Fibrillation Screening with Photo-Plethysmography through a Smartphone Camera. EP Europace, 21, 1167-1175. [Google Scholar] [CrossRef] [PubMed]
[51] Aronsson, M., Svennberg, E., Rosenqvist, M., Engdahl, J., Al-Khalili, F., Friberg, L., et al. (2017) Designing an Optimal Screening Program for Unknown Atrial Fibrillation: A Cost-Effectiveness Analysis. EP Europace, 19, 1650-1656. [Google Scholar] [CrossRef] [PubMed]
[52] Koh, K.T., Law, W.C., Zaw, W.M., Foo, D.H.P., Tan, C.T., Steven, A., et al. (2021) Smartphone Electrocardiogram for Detecting Atrial Fibrillation after a Cerebral Ischaemic Event: A Multicentre Randomized Controlled Trial. EP Europace, 23, 1016-1023. [Google Scholar] [CrossRef] [PubMed]
[53] Andrade, J.G., Shah, A., Godin, R., Lanitis, T., Kongnakorn, T., Brown, L., et al. (2023) Cost-Effectiveness of Atrial Fibrillation Screening in Canadian Community Practice. Heart Rhythm O2, 4, 103-110. [Google Scholar] [CrossRef] [PubMed]
[54] 高晨曦, 陈德芳, 陈清勇, 等. 可穿戴/移动设备在隐匿性心房颤动管理中的应用进展和挑战[J]. 中国全科医学, 2024, 27(30): 3835-3840.
[55] 潘桂俊, 李艳, 石玉霜, 等. 便携式单导联心电仪在社区老年心房颤动筛查中的应用[J]. 上海医药, 2024, 45(2): 39-43.
[56] Tieleman, R.G., Plantinga, Y., Rinkes, D., Bartels, G.L., Posma, J.L., Cator, R., et al. (2014) Validation and Clinical Use of a Novel Diagnostic Device for Screening of Atrial Fibrillation. Europace, 16, 1291-1295. [Google Scholar] [CrossRef] [PubMed]
[57] 邝慧薇, 郑少红, 杨秋娴, 等. 心房颤动快速检测棒在门诊心房颤动机会性筛查的应用[J]. 岭南心血管病杂志, 2024, 30(2): 197-200.
[58] 余莎莎, 刘曼, 刘鸣. 智能穿戴设备在心房颤动检测中的应用价值[J]. 实用心电学杂志, 2024, 33(3): 243-249.
[59] 杨乙珩, 徐荣谦, 张荣峰, 等. 大连市社区老年人群无症状房颤筛查: 一项单中心研究[J]. 中华心血管病杂志, 2023, 51(10): 1056-1062.
[60] 石玉霜, 王惠华, 李艳, 等. 不同心房颤动筛查方式在社区老年人中的效果研究[J]. 中国全科医学, 2024, 27(11): 1316-1319, 1325.
[61] 汤志杰, 孙国珍, 王洁, 等. 早期心房颤动筛查的成本效果分析研究进展[J]. 中国全科医学, 2023, 26(1): 104-112, 117.
[62] Kirchhof, P. (2017) The Future of Atrial Fibrillation Management: Integrated Care and Stratified Therapy. The Lancet, 390, 1873-1887. [Google Scholar] [CrossRef] [PubMed]
[63] 郭海英, 曾辉. 社区心房颤动的综合管理[J]. 中国循证心血管医学杂志, 2023, 15(5): 638-640.
[64] Yue, X., Zhou, L., Li, Y. and Zhao, C. (2024) Multidisciplinary Management Strategies for Atrial Fibrillation. Current Problems in Cardiology, 49, Article ID: 102514. [Google Scholar] [CrossRef] [PubMed]
[65] 杨荣, 刘长明, 廖晓阳, 等. 三级综合医院联合社区医院开展心房颤动综合管理协同路径的探索与思考[J]. 中国全科医学, 2021, 24(1): 36-39.
[66] 肖峰. 基于心脏康复基地的心房颤动社区综合管理, 提升社区卫生服务质量[J]. 中国全科医学, 2022, 25(32): 4003-4004.
[67] 钱丽群, 徐莉苹, 屠丽萍, 等. 上海枫林街道老年心房颤动患者个体化综合管理的效果[J]. 上海医药, 2022, 43(20): 51-54.
[68] 臧梦芳, 张庆勇, 高雷, 等. “1 + 1 + 1”家庭医生签约管理模式在社区老年慢性非瓣膜性房颤患者中的健康管理效果评价研究[J]. 山西医药杂志, 2022, 51(21): 2479-2482.
[69] 牛慧琴, 马小艳. 家庭医生团队签约模式对老年房颤患者健康管理的效果研究[J]. 名医, 2021(4): 179-180.
[70] 李军, 姜小飞, 陈曦, 等. 老年房颤患者华法林抗凝治疗社区管理与专科管理的对比研究[J]. 华西医学, 2010, 25(1): 155-158.
[71] 张凤艳, 冯天元, 徐建, 等. 农村社区房颤患者综合管理效果评价[J]. 浙江临床医学, 2018, 20(10): 1678-1680.
[72] 刘艳丽, 马力. 社区心房颤动患者筛查及多学科协作的综合管理模式研究[J]. 中国全科医学, 2020, 23(7): 774-778.
[73] 闫静静, 秦明照. 中国老年心房颤动患者抗凝治疗现状及分析[J]. 中国全科医学, 2018, 21(27): 3285-3289.
[74] 戚玉勤, 金雪娟, 李双, 等. 上海市社区老年人群心房颤动的流行病学特征及抗凝治疗现状调查[J]. 中国临床医学, 2018, 25(1): 1-4.
[75] 段园霞, 顾柳娜, 张磊, 等. 基层医务人员心房颤动相关知识掌握情况及影响因素分析[J]. 中国全科医学, 2023, 26(7): 869-876.
[76] 周丽婷, 张磊, 段园霞, 等. 上海市奉贤区基层全科医生对心房颤动的临床认知情况的调查研究[J]. 全科医学临床与教育, 2023, 21(4): 356-359.
[77] 段园霞, 潘志刚, 顾杰, 等. 社区老年非瓣膜性心房颤动患者抗凝治疗现状及影响因素研究[J]. 中国全科医学, 2022, 25(25): 3114-3121.
[78] Siu, C. and Tse, H. (2014) Net Clinical Benefit of Warfarin Therapy in Elderly Chinese Patients with Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology, 7, 300-306. [Google Scholar] [CrossRef] [PubMed]
[79] Steinhubl, S.R., Waalen, J., Sanyal, A., Edwards, A.M., Ariniello, L.M., Ebner, G.S., et al. (2021) Three Year Clinical Outcomes in a Nationwide, Observational, Siteless Clinical Trial of Atrial Fibrillation Screening—mHealth Screening to Prevent Strokes (mSToPS). PLOS ONE, 16, e0258276. [Google Scholar] [CrossRef] [PubMed]